Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Berkshire buys Teva, feels IBM blues as Apple becomes top investment

Published 02/14/2018, 06:01 PM
© Reuters. FILE PHOTO: Berkshire Hathaway shareholders walking by a video screen at the company's annual meeting in Omaha
GM
-
JPM
-
SASY
-
TEVA
-
AAPL
-
AMZN
-
WFC
-
IBM
-
USB
-
BK
-
MON
-
TEVA
-
BRKa
-
PSX
-
AAL
-

By Jonathan Stempel

(Reuters) - Warren Buffett's Berkshire Hathaway Inc (N:BRKa) on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical (NYSE:TEVA) Industries Ltd (TA:TEVA) and said it bought more shares of Apple Inc (O:AAPL), which surpassed Wells Fargo & Co (N:WFC) as its largest common stock investment.

Berkshire also nearly completed its yearlong exit from International Business Machines Corp (N:IBM), selling more than 94 percent of what was left from an investment Buffett has admitted was not among his best.

In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million Teva American depositary receipts, worth about $358 million.

Teva shares rose more than 10 percent after market hours, reflecting what investors perceive as Berkshire's seal of approval for the Israeli drugmaker.

Last month, Berkshire said it would work with Amazon.com Inc (O:AMZN) and JPMorgan Chase & Co (N:JPM) to create their own healthcare company. Other healthcare stocks fell on that news.

"The intimidation, bullying and misery facing the healthcare industry has created bargains," said Bill Smead, who oversees $2.3 billion, including $130 million in Berkshire stock, at Smead Capital Management Inc in Seattle.

Teva and Berkshire declined to comment.

Wednesday's filing details investments made by Buffett and his investment deputies Todd Combs and Ted Weschler, though it does not say who bought what. Combs and Weschler are generally responsible for Berkshire's smaller investments.

Berkshire's Apple stake grew by about 23 percent since the end of September to roughly 165.3 million shares worth $28 billion. That was just above the reported $27.8 billion stake in Wells Fargo.

Berkshire may have funded the Apple purchases by selling roughly $5 billion of IBM stock, reducing that stake to just 2.05 million shares worth about $314 million.

Buffett began selling IBM in the first quarter of 2017, and has admitted he did not value the company as highly as when he began buying six years earlier.

Berkshire at one time owned roughly 81 million IBM shares, for which it paid about $13.8 billion. Berkshire was close to break-even on IBM when the selling began.

Berkshire on Wednesday also reported higher stakes in Bank of New York Mellon Corp (N:BK), Monsanto Co (N:MON) and US Bancorp (N:USB), and lower stakes in American Airlines Group Inc (O:AAL), General Motors Co (N:GM), France's Sanofi SA (PA:SASY) and Wells Fargo.

On Tuesday, Berkshire agreed to sell more than 43 percent of another big holding, Phillips 66 (N:PSX), back to the oil refiner for $3.3 billion. It plans to remain a long-term shareholder.

© Reuters. FILE PHOTO: Berkshire Hathaway shareholders walking by a video screen at the company's annual meeting in Omaha

Buffett will provide more detail about Berkshire's investments and its more than 90 operating businesses in his annual shareholders letter, slated for release on Feb. 24.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.